Published in ASAIO J on March 12, 1996
Pediatric ventricular assist devices. Pediatr Cardiol (2007) 0.86
Ventricular assist devices in pediatrics. Images Paediatr Cardiol (2001) 0.80
The Berlin Heart EXCOR in an 11-year-old boy: a bridge to recovery after myocardial infarction. Tex Heart Inst J (2007) 0.75
The use of anticoagulation in pediatric cardiac disease. Images Paediatr Cardiol (2003) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg (2001) 2.80
Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29
Implantable left ventricular assist devices. N Engl J Med (1998) 2.07
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Pediatric cardiac surgery: the effect of hospital and surgeon volume on in-hospital mortality. Pediatrics (1998) 1.87
L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation (1997) 1.83
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest (1996) 1.81
A regional survey of health insurance coverage for complementary and alternative medicine: current status and future ramifications. J Altern Complement Med (2001) 1.77
Therapy for primary cardiac tumors: is there a role for heart transplantation? Curr Opin Cardiol (2000) 1.77
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood (1995) 1.73
Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg (2001) 1.68
Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr (2001) 1.67
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58
Outflow obstruction after the arterial switch operation: a multiinstitutional study. Congenital Heart Surgeons Society. J Thorac Cardiovasc Surg (1997) 1.58
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
Cerebral blood flow is determined by arterial pressure and not cardiopulmonary bypass flow rate. Ann Thorac Surg (1995) 1.55
Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation (1995) 1.49
The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49
Preservation of anterior leaflet chordae tendineae during mitral valve replacement. Ann Thorac Surg (1994) 1.47
Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg (1997) 1.47
Influence of technique of coronary artery implantation on long-term results in composite aortic root replacement. Ann Thorac Surg (2001) 1.47
Pediatric transplantation in the United States, 1997-2006. Am J Transplant (2008) 1.46
Acute pulmonary embolism in pediatric patients awaiting heart transplantation. J Am Coll Cardiol (1991) 1.43
Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation (1995) 1.42
Surgical management of cardiac pheochromocytoma. Resection versus transplantation. Ann Surg (1995) 1.42
Surgery for membranous subaortic stenosis. Long-term follow-up. Eur J Cardiothorac Surg (1993) 1.41
Pediatric cardiac transplantation using hearts previously refused for quality: a single center experience. Am J Transplant (2013) 1.41
Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg (1994) 1.40
Comparative roles of intraoperative epicardial and early postoperative transthoracic echocardiography in the assessment of surgical repair of congenital heart defects. J Am Coll Cardiol (1990) 1.40
Tracheobronchial anomalies in children with congenital cardiac disease. J Cardiothorac Vasc Anesth (1998) 1.40
Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med (2000) 1.40
Isolated cerebral hypothermia by single carotid artery perfusion of extracorporeally cooled blood in baboons. Neurosurgery (1996) 1.39
Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg (1998) 1.39
Discrepancy between claimed field flux density of some commercially available magnets and actual gaussmeter measurements. Altern Ther Health Med (2001) 1.39
Glucose versus lactated Ringer's solution during pediatric cardiac surgery. J Cardiothorac Vasc Anesth (1997) 1.39
Retrograde cardioplegia preserves myocardial function after induced coronary air embolism. J Thorac Cardiovasc Surg (1997) 1.38
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation (2000) 1.32
Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg (1999) 1.28
Experience with heart transplantation for cardiac tumors. J Heart Lung Transplant (1995) 1.28
Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med (1997) 1.24
Survival and risk factor analysis for the Norwood procedure for hypoplastic left heart syndrome. Am J Cardiol (1997) 1.24
Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood (1995) 1.23
Early and late results of surgical treatment of congenital coronary artery fistula. Thorax (1987) 1.22
Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation (2000) 1.21
Novel technique to repair type A acute aortic dissection in patients with a left ventricular assist device. Ann Thorac Surg (2001) 1.21
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation (1997) 1.20
The arterial switch operation. An eight-year experience. J Thorac Cardiovasc Surg (1986) 1.19
Congenital discrete subvalvar aortic stenosis. Surgical experience and long-term follow-up in 20 paediatric patients. Br Heart J (1973) 1.17
Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation (1995) 1.16
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16
Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg (1999) 1.16
Outcomes in patients with interrupted aortic arch and ventricular septal defect. A multiinstitutional study. Congenital Heart Surgeons Society. J Thorac Cardiovasc Surg (1994) 1.16
Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. J Heart Lung Transplant (1996) 1.14
Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg (2001) 1.14
Revival of the Senning operation in the treatment of transposition of the great arteries. Preliminary report on recent experience. Thorax (1977) 1.13
Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest (1994) 1.13
De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13
Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation (1997) 1.13
Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation (2006) 1.12
Changes in type I collagen following laser welding. Lasers Surg Med (1992) 1.12
Bilateral internal thoracic artery harvesting under robotic video-assistance. Surg Endosc (2001) 1.11
A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg (2000) 1.11
Juxtaductal pulmonary artery coarctation. An underestimated cause of branch pulmonary artery stenosis in patients with pulmonary atresia or stenosis and a ventricular septal defect. J Thorac Cardiovasc Surg (1990) 1.11
Novel technique for extending the use of allografts in cardiac operations. Ann Thorac Surg (1994) 1.11
Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest (1994) 1.10
Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation (1994) 1.09
Hepatobiliary complications of polyarteritis nodosa. Arch Surg (1991) 1.09
Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. Proc Natl Acad Sci U S A (1997) 1.08
Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg (1997) 1.08
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg (2000) 1.08
Noncardiac surgery in long-term implantable left ventricular assist-device recipients. Ann Surg (1995) 1.06
The association of tracheal anomalies and tetralogy of Fallot. J Cardiothorac Vasc Anesth (1996) 1.06
Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2000) 1.04
The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol (2001) 1.04
Traumatic tricuspid insufficiency. An underdiagnosed disease. Chest (1987) 1.03
The trousers-shaped baffle for use in the Mustard operation. Ann Thorac Surg (1978) 1.03
The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant (1997) 1.03
Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol (1994) 1.02
Long-term results of atrial correction for transposition of the great arteries. Comparison of Mustard and Senning operations. J Thorac Cardiovasc Surg (1994) 1.02
Xenotransplantation: risks, clinical potential, and future prospects. Emerg Infect Dis (1996) 1.02
100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg (1999) 1.01